Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion type Assertion NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_head.
- NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion description "[The frequency and precise loss of CDKN2B(INK4b), CDKN2A(ARF, INK4a), and MTAP in the prognosis of 9p21-deleted HNSCC may provide impetus for use of these targets as therapeutic biomarkers in head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_provenance.
- NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion evidence source_evidence_literature NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_provenance.
- NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion SIO_000772 16618910 NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_provenance.
- NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion wasDerivedFrom befree-2016 NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_provenance.
- NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_assertion wasGeneratedBy ECO_0000203 NP545308.RAllIVPgd5w84kXU4nh2RZizNT0zRtCLUFd50ClAgC0PI130_provenance.